COMMUNIQUÉS West-GlobeNewswire

ASHA Congratulates The Pitt for Its Emmy Awards
15/09/2026
TV Medical Drama Spotlights the Importance of Effective Communication Rockville, MD, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The American Speech-Language-Hearing Association (ASHA) congratulates the TV series The Pitt for [...]
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
15/09/2026
Abbreviated New Drug Application (ANDA) Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment. FDA has revised the Generic Drugs User Fee Act [...]
Acquisition of Own Shares
15/09/2026
Mechelen, Belgium; 15 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
15/09/2026
-Transaction complements Tempest’s existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in vivo CAR-T candidate [...]
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
15/09/2026
Lisa Pitt, Pharm.D., M.S.J. appointed Senior Vice President, Regulatory Affairs Shiguang Liu, M.D., Ph.D. appointed Vice President, Clinical Development REDWOOD CITY, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Jasper [...]
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
15/09/2026
HIGH POINT, N.C., Sept. 15, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin , a novel, potential first-in-class oral [...]
Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock
15/09/2026
IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $125 [...]
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
15/09/2026
Registration is now open for Cronos’ first Investor Day, which will be hosted by the Cronos Leadership Team, on September 24, 2026 TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON [...]
Patterson Veterinary Launches Atlas: an AI Assistant for Veterinary Software
15/09/2026
Atlas AI is built into NaVetor and also works with other veterinary software platforms ST. PAUL, Minn., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Patterson Veterinary today announced the launch of Atlas , a new veterinary [...]
USAHS Brings Healthcare Professionals Together to Spark Action on Workplace Mental Health
15/09/2026
The event will offer practical strategies to healthcare professionals and students in rehabilitative health sciences programs. ST. AUGUSTINE, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- The University of St. Augustine for [...]
FemPulse Clinical Data to be Presented at ICS on October 9
15/09/2026
VIENNA and SAN FRANCISCO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that data from two recent clinical [...]
Elevar Therapeutics Submits Marketing Authorization Application to European Medicines Agency for Lirafugratinib as a Treatment for Patients with Advanced/Metastatic Cholangiocarcinoma (CCA) Harboring FGFR2 Fusions or Rearrangements
15/09/2026
Submission initiates regulatory process in European Union following U.S. submission, expanding global market presence Lirafugratinib is a highly selective, irreversible FGFR2 inhibitor differentiated from existing pan- [...]
Correction: IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 36 - 2026
15/09/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 31 août au 4 septembre 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Correction: IPSEN - Buy-back programme - Art 5 of MAR - Week 36- 2026
15/09/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 31st August to 04th September 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
Provincial funding will expand access to team-based primary care in North Western Toronto
15/09/2026
Unison Health & Community Services and Humber River Health partnership will connect more residents to ongoing, community-based care TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Unison Health & Community Services [...]
ENvue Medical Provides Nasdaq Listing Update
15/09/2026
TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (Nasdaq: FEED) (“ENvue” or the “Company”), a medical technology company focused on innovative solutions for enteral feeding and therapeutic ultrasound [...]
World’s largest vision award goes to Botond Roska and José-Alain Sahel
15/09/2026
Basel, 15 September 2026 - Botond Roska, Director of Science at the Institute of Molecular and Clinical Ophthalmology Basel (IOB), and José-Alain Sahel, University of Pittsburgh and Chair of the IOB Scientific Advisory [...]
Lobular Breast Cancer Alliance Launches Cross-Country Awareness Tour to Address Breast Cancer Visibility Gap
15/09/2026
Boston, USA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- “It’s Time to Talk About Lobular Breast Cancer” campaign will travel from San Francisco to Boston, bringing urgently needed national attention to invasive lobular [...]
Egle Therapeutics to Present Clinical Data at the Upcoming European Academy of Dermatology and Venereology (EADV) Congress in Vienna
15/09/2026
Egle to share clinical data on EGL-003, the company's most advanced Treg-selective IL-2 agonist for atopic dermatitis PARIS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics (“Egle”), a clinical-stage biotechnology [...]

Pages